AU2001264043A1 - 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparationand therapeutic use thereof - Google Patents
4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparationand therapeutic use thereofInfo
- Publication number
- AU2001264043A1 AU2001264043A1 AU2001264043A AU6404301A AU2001264043A1 AU 2001264043 A1 AU2001264043 A1 AU 2001264043A1 AU 2001264043 A AU2001264043 A AU 2001264043A AU 6404301 A AU6404301 A AU 6404301A AU 2001264043 A1 AU2001264043 A1 AU 2001264043A1
- Authority
- AU
- Australia
- Prior art keywords
- preparationand
- phenylthiazol
- diazabicyclo
- therapeutic use
- nonane derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006978 | 2000-05-31 | ||
FR0006978A FR2809732B1 (en) | 2000-05-31 | 2000-05-31 | DERIVATIVES OF 4 (-2-PHENYLTHIAZOL-5-yl) -1,4-DIAZABICYCLO- [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPY APPLICATION |
PCT/FR2001/001650 WO2001092260A1 (en) | 2000-05-31 | 2001-05-29 | 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001264043A1 true AU2001264043A1 (en) | 2001-12-11 |
Family
ID=8850829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001264043A Abandoned AU2001264043A1 (en) | 2000-05-31 | 2001-05-29 | 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparationand therapeutic use thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US7001902B2 (en) |
EP (1) | EP1289987B1 (en) |
JP (1) | JP4939720B2 (en) |
AR (1) | AR028649A1 (en) |
AT (1) | ATE267201T1 (en) |
AU (1) | AU2001264043A1 (en) |
DE (1) | DE60103394T2 (en) |
FR (1) | FR2809732B1 (en) |
HU (1) | HU229600B1 (en) |
TW (1) | TW591028B (en) |
WO (1) | WO2001092260A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000540D0 (en) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
FR2832713B1 (en) | 2001-11-23 | 2004-02-13 | Sanofi Synthelabo | DERIVATIVES OF 4- (1,3,4-THIADIAZOL-2-YL) -1,4-DIAZABICYCLO [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
SE0202465D0 (en) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
SE0202430D0 (en) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
CA2499128C (en) | 2002-09-25 | 2012-07-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
SI1551835T1 (en) * | 2002-09-30 | 2007-06-30 | Neurosearch As | Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
DK1551835T3 (en) * | 2002-09-30 | 2007-06-04 | Neurosearch As | Newly known 1,4-diazabicycloalkane derivatives, their preparation and use |
DE60309740T2 (en) * | 2002-11-11 | 2007-03-29 | Neurosearch A/S | 1,4-DIZABICYCLO (3,2,2) NONANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTICAL USE |
US7223753B2 (en) | 2002-11-11 | 2007-05-29 | Neurosearch A/S | Diazabicyclic biaryl derivatives |
US7396833B2 (en) | 2003-12-22 | 2008-07-08 | Memory Pharmaceuticals Corporation | Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
US20080227772A1 (en) * | 2004-02-04 | 2008-09-18 | Neurosearch A/S | Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands |
DK1713487T3 (en) * | 2004-02-04 | 2010-04-06 | Neurosearch As | Diazabicyclic aryl derivatives as cholinergic receptor modulators |
RU2417225C2 (en) | 2004-03-25 | 2011-04-27 | Мемори Фармасьютиклз Корпорейшн | Indazoles, bentothiazoles, benzoisothiazoles, benzisoxazoles and synthesis and use thereof |
ATE487716T1 (en) | 2004-04-22 | 2010-11-15 | Memory Pharm Corp | INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, 1,2-BENZOISOTHIAZOLES, THEIR PRODUCTION AND USES |
AU2005243147A1 (en) * | 2004-05-07 | 2005-11-24 | Memory Pharmaceuticals Corporation | 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
WO2006065209A1 (en) * | 2004-12-15 | 2006-06-22 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
JP2008525464A (en) | 2004-12-22 | 2008-07-17 | メモリー・ファーマシューティカルズ・コーポレイション | Alpha-7 nicotinic receptor ligand and its production and use |
ATE495178T1 (en) | 2005-02-16 | 2011-01-15 | Neurosearch As | DIAZABICYCLIC ARYL DERIVATIVES AND THEIR USE AS QUINOLINERGIC LIGANDS ON NICOTINE-ACETYLCHOLINE RECEPTORS |
US8106066B2 (en) | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
WO2007065892A1 (en) | 2005-12-06 | 2007-06-14 | Neurosearch A/S | Novel diazabicyclic aryl derivatives and their medical use |
EP2029607A1 (en) | 2006-05-23 | 2009-03-04 | NeuroSearch A/S | Novel 8,10-diaza-bicycloý4.3.1¨decane derivatives and their medical use |
DK2032574T3 (en) * | 2006-05-30 | 2010-09-20 | Neurosearch As | Newly known 1,4-diaza-bicyclo [3.2.2] nonyloxadiazolyl derivatives and their medical use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166416B (en) * | 1985-09-18 | 1990-05-05 | Pfizer | |
NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
FR2786770B1 (en) | 1998-12-04 | 2001-01-19 | Synthelabo | NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
-
2000
- 2000-05-31 FR FR0006978A patent/FR2809732B1/en not_active Expired - Fee Related
-
2001
- 2001-05-29 AU AU2001264043A patent/AU2001264043A1/en not_active Abandoned
- 2001-05-29 JP JP2002500873A patent/JP4939720B2/en not_active Expired - Fee Related
- 2001-05-29 EP EP01938362A patent/EP1289987B1/en not_active Expired - Lifetime
- 2001-05-29 HU HU0302157A patent/HU229600B1/en not_active IP Right Cessation
- 2001-05-29 US US10/276,822 patent/US7001902B2/en not_active Expired - Lifetime
- 2001-05-29 AT AT01938362T patent/ATE267201T1/en not_active IP Right Cessation
- 2001-05-29 DE DE60103394T patent/DE60103394T2/en not_active Expired - Lifetime
- 2001-05-29 WO PCT/FR2001/001650 patent/WO2001092260A1/en active IP Right Grant
- 2001-05-30 TW TW090113055A patent/TW591028B/en not_active IP Right Cessation
- 2001-05-30 AR ARP010102576A patent/AR028649A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP4939720B2 (en) | 2012-05-30 |
EP1289987B1 (en) | 2004-05-19 |
FR2809732B1 (en) | 2002-07-19 |
DE60103394T2 (en) | 2005-06-02 |
JP2003535090A (en) | 2003-11-25 |
US20040029884A1 (en) | 2004-02-12 |
ATE267201T1 (en) | 2004-06-15 |
EP1289987A1 (en) | 2003-03-12 |
HUP0302157A2 (en) | 2003-10-28 |
TW591028B (en) | 2004-06-11 |
WO2001092260A1 (en) | 2001-12-06 |
US7001902B2 (en) | 2006-02-21 |
HUP0302157A3 (en) | 2011-03-28 |
DE60103394D1 (en) | 2004-06-24 |
FR2809732A1 (en) | 2001-12-07 |
HU229600B1 (en) | 2014-02-28 |
AR028649A1 (en) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264043A1 (en) | 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparationand therapeutic use thereof | |
AU2002356256A1 (en) | 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof | |
ZA200306341B (en) | Imidazo (1,2-a)-pyridine derivatives as mGluR5 antagonists. | |
AU2002361992A1 (en) | 1,4-dihydro-1,4-diphenylpyridine derivatives | |
AU2001277032A1 (en) | 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 ones | |
AU2001295481A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2001287694A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
HUP0401648A3 (en) | 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same | |
AU2001230026A1 (en) | 2,4-diaminothiazole derivatives | |
HK1068895A1 (en) | Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor | |
MXPA03001483A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
HK1046909A1 (en) | Piperazine derivatives as 5-ht1b antagonists. | |
AU2001284021A1 (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2002361326A1 (en) | 4-(oxadiazol-3-yl)-1,4-diazabicyclo(3.2.2)-nonane derivatives, preparation and therapeutic use thereof | |
AU2003216934A1 (en) | Benzoxazinone derivatives, the preparation and use thereof as medicaments | |
AU2001262221A1 (en) | Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use | |
AU2001241056A1 (en) | Spiro compounds, process for preparing the same and use thereof as drugs | |
AU2001289814A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
WO2002094020A8 (en) | Use of triazolopyrimidine derivatives as microbicides in the protection of materials | |
AU2001294228A1 (en) | Benzimidazole compounds, process for producing the same and use thereof | |
PL367179A1 (en) | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds | |
AU2002232468A1 (en) | Pharmaceutical heterocyclic compounds | |
MXPA02005011A (en) | Novel thiazolidinedione derivatives as antidiabetic agents. | |
AU2001258841A1 (en) | Heterocyclic compounds | |
MXPA00011504A (en) | Substituted heterocyclic derivatives. |